Neurological Disorder Diagnostics Market Size, Share, By Product (Imaging Systems and In-vitro Diagnostics), Disease Indication (Strokes, Multiple Sclerosis, Neurodegenerative Diseases, Headaches, Sleep Disorder, and Others), End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Region - Trends, Analysis, and Forecast till 2035

Report Code: PMI75819 | Publish Date: April 2024 | No. of Pages: 180

Global Neurological Disorder Diagnostics Market Share

By Region, the neurological disorder diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. 

North America is dominating region for neurological disorder diagnostics market due to well-developed healthcare infrastructure, technological advancement in countries such as U.S. and Canada. North America contains leading neurodiagnostic device manicuring companies such as GE Healthcare, Siemens Healthineers, and others that lead to drive target market.

Asia Pacific is expected to be a growing region in the target market, as the raising number of neurodegenerative diseases, growing health awareness, expanding healthcare infrastructure in countries, such as China, India, and other Asian regions. The manufacturing companies’ partnerships and government initiatives aimed to making affordable healthcare, resulting to drive target market in upcoming years.